Novel Treatment Appears to Show Benefit in ALS

(MedPage Today) -- DENVER -- A novel treatment candidate for amyotrophic lateral sclerosis (ALS) met its primary safety and secondary endpoints in the phase IIb PARADIGM trial. ALS patients treated with PrimeC -- a formulation of two FDA-approved...
Source: MedPage Today Neurology - Category: Neurology Source Type: news
More News: ALS | Brain | Neurology